Medical (incl. medical device & pharma), US Foreign Corrupt Practices Act & Dodd Frank - Written by Barry & Richard on Tuesday, November 23, 2010 3:23 - 0 Comments
Pharmaceutical businesses and the stark warning from the SFO
It has been well publicised that the pharmaceutical sector has been under increasing scrutiny from US regulators. Mr. Alderman spoke at a UK pharmaceutical conference about the industry, the Bribery Act and the SFO’s close co-operation with the US Department of Justice which is involved in a Foreign Corrupt Practices Act investigation into the pharmaceutical sector in the US.